Belosalik, ointment 40 g

A drug with anti-inflammatory, antipruritic, antiproliferative, antimicrobial and keratolytic action for external use.

Betamethasone has anti-inflammatory, antiallergic, antiproliferative and antipruritic effects.

When applied to the surface of the skin, betamethasone has a fast and strong action in the focus of inflammation, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).

Salicylic acid has a keratolytic effect which cleanses the lesion of scales, facilitates penetration of betamethasone into the skin and maintains the acidic skin environment, preventing the development of bacterial and fungal infection.

Indications

Subacute and chronic dermatoses for which therapy with topical GCS is effective, and accompanied by hyperkeratosis and peeling, including:

The drug in the form of a solution for external use is indicated for use on the scalp and in children 6 months and older.

Active ingredient

Composition

1 g of the ointment contains:

The active ingredients:

betamethasone dipropionate – 640 mcg, which corresponds to the content of betamethasone – 500 mcg;

salicylic acid 30 mg.

Auxiliary substances:

mineral oil,

Vaseline.

How to take, the dosage

The drug is intended for external use.

A small amount of the ointment is spread evenly over the surface of the skin, rubbing it gently. The frequency of use is 2 times a day; in mild cases a single use is sufficient.

The duration of the continuous course of treatment is usually limited to 3-4 weeks. If a longer course of therapy is necessary, it is recommended to use the drug less frequently, for example, every other day.

In the therapy of chronic conditions, treatment should continue for some time after all symptoms have disappeared, under a physician’s supervision, to avoid a recurrence of the disease.

Repeat courses of therapy are possible within a year.

Interaction

There have been no clinically significant interactions with other medications.

The simultaneous use of cosmetic and dermatological agents

The use of dermatological agents has not been reported.

Special Instructions

The ointment is for external use on the skin and/or scalp only.

Contact of the ointment with the eyes and mucous membranes should be avoided.

Long-term use of the ointment on the face is not recommended because of the possible development of rosacea-type dermatitis, perioral dermatitis, skin atrophy and acne.

The use of the drug in the anogenital area should be avoided.

The use of the drug under an occlusive dressing is not recommended except when necessary. If fungal or bacterial microflora develops on the skin, additional use of an antibacterial or antifungal agent is necessary.

Pediatric use

The use of Belosalik in children should be as short as possible with strict precautions, since in children there is a risk of systemic absorption of a proportionally greater amount of the active ingredients due to the predominance of skin area over body weight and insufficient maturity of the epidermis. The drug should not be used in children under bandages and especially under plastinated diapers, which may increase the risk of adverse events.

Influence on driving and operating ability

There are no data on adverse effects of Belosalik on driving and operating ability.

Contraindications

Side effects

The side effects are usually mild.

Dermatological reactions: hypersensitivity reactions may develop (itching, burning, hyperemia); rarely – acne-like changes, hypopigmentation, stretch marks, skin atrophy, hypertrichosis, telangiectasia, secondary skin infections.

In long-term continuous use and in large areas of the skin: Betamethasone may cause systemic adverse reactions associated with suppression of adrenal cortical function.

The drug should be stopped if hypersensitivity or adverse reactions develop.

Pregnancy use

The use of the drug Belosalik (in the form of ointment and/or solution for external use) in pregnant women is allowed in cases when the expected benefits to the mother exceed the risk to the fetus.

In such cases, the use of the drug should be short and limited to small areas of the skin.

When breastfeeding, Belosalik may be used for strict indications, but the drug should not be applied to the breast skin before breastfeeding.

Similarities